CN115813975B - Plant essential oil for resolving depression and aiding sleep and application thereof - Google Patents
Plant essential oil for resolving depression and aiding sleep and application thereof Download PDFInfo
- Publication number
- CN115813975B CN115813975B CN202111672955.8A CN202111672955A CN115813975B CN 115813975 B CN115813975 B CN 115813975B CN 202111672955 A CN202111672955 A CN 202111672955A CN 115813975 B CN115813975 B CN 115813975B
- Authority
- CN
- China
- Prior art keywords
- oil
- essential oil
- plant essential
- sleep
- aiding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000341 volatile oil Substances 0.000 title claims abstract description 44
- 238000000605 extraction Methods 0.000 claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 12
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 8
- 241000196324 Embryophyta Species 0.000 claims description 49
- 239000003921 oil Substances 0.000 claims description 34
- 241000222336 Ganoderma Species 0.000 claims description 12
- 235000006708 antioxidants Nutrition 0.000 claims description 11
- 235000017276 Salvia Nutrition 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- 239000010659 mugwort oil Substances 0.000 claims description 8
- 240000008397 Ganoderma lucidum Species 0.000 claims description 7
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 6
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 5
- 229940087168 alpha tocopherol Drugs 0.000 claims description 4
- 238000004821 distillation Methods 0.000 claims description 4
- 229960000984 tocofersolan Drugs 0.000 claims description 4
- 235000004835 α-tocopherol Nutrition 0.000 claims description 4
- 239000002076 α-tocopherol Substances 0.000 claims description 4
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 125000001020 α-tocopherol group Chemical group 0.000 claims description 2
- 241001072909 Salvia Species 0.000 claims 3
- 230000036651 mood Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 23
- 239000002244 precipitate Substances 0.000 abstract description 15
- 208000019901 Anxiety disease Diseases 0.000 abstract description 5
- 230000036506 anxiety Effects 0.000 abstract description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 3
- 206010022437 insomnia Diseases 0.000 abstract description 3
- 206010013954 Dysphoria Diseases 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 230000003860 sleep quality Effects 0.000 abstract description 2
- 235000019198 oils Nutrition 0.000 description 28
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 235000019441 ethanol Nutrition 0.000 description 8
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 7
- 240000007164 Salvia officinalis Species 0.000 description 7
- OMOVVBIIQSXZSZ-UHFFFAOYSA-N [6-(4-acetyloxy-5,9a-dimethyl-2,7-dioxo-4,5a,6,9-tetrahydro-3h-pyrano[3,4-b]oxepin-5-yl)-5-formyloxy-3-(furan-3-yl)-3a-methyl-7-methylidene-1a,2,3,4,5,6-hexahydroindeno[1,7a-b]oxiren-4-yl] 2-hydroxy-3-methylpentanoate Chemical compound CC12C(OC(=O)C(O)C(C)CC)C(OC=O)C(C3(C)C(CC(=O)OC4(C)COC(=O)CC43)OC(C)=O)C(=C)C32OC3CC1C=1C=COC=1 OMOVVBIIQSXZSZ-UHFFFAOYSA-N 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 6
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 5
- 235000003097 Artemisia absinthium Nutrition 0.000 description 5
- 240000001851 Artemisia dracunculus Species 0.000 description 5
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 5
- 239000001138 artemisia absinthium Substances 0.000 description 5
- 238000002791 soaking Methods 0.000 description 5
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 4
- 239000010670 sage oil Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 240000006891 Artemisia vulgaris Species 0.000 description 2
- 241000304195 Salvia miltiorrhiza Species 0.000 description 2
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 2
- 230000000949 anxiolytic effect Effects 0.000 description 2
- 238000000222 aromatherapy Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- -1 tea polyphenol Chemical class 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 241000132064 Ainsliaea Species 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 241000195620 Euglena Species 0.000 description 1
- LLQPHQFNMLZJMP-UHFFFAOYSA-N Fentrazamide Chemical compound N1=NN(C=2C(=CC=CC=2)Cl)C(=O)N1C(=O)N(CC)C1CCCCC1 LLQPHQFNMLZJMP-UHFFFAOYSA-N 0.000 description 1
- 244000143590 Salvia chinensis Species 0.000 description 1
- 235000007154 Salvia chinensis Nutrition 0.000 description 1
- 235000005794 Salvia japonica Nutrition 0.000 description 1
- 235000002912 Salvia officinalis Nutrition 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Fats And Perfumes (AREA)
Abstract
The invention relates to A61K8, in particular to plant essential oil for resolving depression and aiding sleep and application thereof. The plant essential oil for resolving depression and aiding sleep comprises plant components and an antioxidant. The fragrance-expanding performance of the finally obtained plant essential oil is improved by adding specific plant components. The obtained plant essential oil has high stability, does not deteriorate after long-term storage, does not produce precipitate, and does not change color. Can relieve stress and tension, relieve dysphoria and anxiety, improve sleep quality, and improve insomnia; the temperature, time and other conditions in the alcohol extraction process are controlled, so that the obtained substances are mixed in the system and perform functions.
Description
Technical Field
The invention relates to A61K8, in particular to plant essential oil for resolving depression and aiding sleep and application thereof.
Background
Along with the rapid development of social economy, the work and life rhythms are obviously accelerated, the psychological stress of people is continuously increased, more and more people start to generate anxiety, the anxiety can cause a plurality of negative injuries to the body, and insomnia can be caused in severe cases.
Aromatherapy with essential oils is a useful method of alleviating anxiety, but aromatherapy essential oils generally have too short a shelf life due to the absence of preservatives.
The patent number CN105395525B provides an agilawood essential oil cataplasm with an anxiolytic effect and a preparation method thereof, and the agilawood essential oil cataplasm paste obtained by adding carbomer, agilawood essential oil and the like has fine appearance and comfortable smell and has a better anxiolytic effect.
Disclosure of Invention
In order to solve the problems, the first aspect of the invention provides plant essential oil for resolving depression and aiding sleep, wherein the raw materials of the plant essential oil for resolving depression and aiding sleep comprise plant components and antioxidants.
As a preferable technical scheme of the invention, the plant component is one or more selected from mugwort oil, salvia oil, ganoderma oil, cassia seed oil and sage oil.
Preferably, the weight ratio of the Salvia oil, oleum Artemisiae Argyi, and Ganoderma oil in the plant components is (8-12): (7-10): (3-6): (5-7.5).
Further preferably, the weight ratio of the euglena oil, the sage oil, the wormwood oil and the ganoderma lucidum oil in the plant components is 10:8:5:6.
as a preferred technical scheme of the invention, the antioxidant is selected from one or more of alpha-tocopherol, vitamin E, tocopheryl acetate and tea polyphenol.
Preferably, the plant essential oil for resolving depression and aiding sleep comprises, by weight, 24-32 parts of plant components and 0.4-0.7 part of antioxidants.
The applicant finds through a large number of experiments that the addition of specific plant components and antioxidants into the plant essential oil is beneficial to improving the fragrance-expanding performance of the finally obtained plant essential oil and can also improve the stability of a system. This is probably due to the interaction of the specific proportions of the Salvia oil, the mugwort oil, the Ganoderma oil and the specific antioxidant molecules, which improves the dispersibility of each substance in the system and strengthens the intermolecular forces, thus making the system more stable.
As a preferable technical scheme of the invention, the mugwort oil and the ganoderma oil are obtained through an alcohol extraction process.
As a preferable technical scheme of the invention, the alcohol extraction process comprises the following steps: (1) crushing; (2) extraction; (3) extracting; (4) filtration and distillation.
Preferably, the grinding is specifically to grind mugwort or lucid ganoderma by a grinder and then pass through a 20-mesh sieve to obtain the substance A.
As a preferred embodiment of the present invention, an organic solvent is used in the extraction process.
Preferably, the organic solvent is ethyl acetate.
As a preferred embodiment of the present invention, the organic solvent has a density of 0.8-1.0g/mL.
Preferably, the extraction is specifically that the substance A is soaked in ethyl acetate with the weight being 16-18 times of that of the substance A for 12-15 days, and the substance A is taken out and placed in an oven with the temperature being 60-80 ℃ for drying for 12 hours, so that the substance B is obtained.
As a preferred embodiment of the invention, the extraction requires the addition of alcohols.
Preferably, the alcohol is specifically absolute ethanol.
The extraction is specifically that absolute ethyl alcohol with the weight of 8-12 times is added into the substance B, and the substance C is obtained after soaking for 15 days.
And (4) filtering the substance C, and distilling the filtered filtrate under reduced pressure at 40 ℃ and a vacuum degree of 10mbar for 4-6 hours to obtain extract, namely the wormwood oil or the ganoderma lucidum oil.
The second aspect of the invention provides a preparation method of the plant essential oil for resolving depression and aiding sleep, and the plant essential oil for resolving depression and aiding sleep is applied to improve emotion.
Compared with the prior art, the invention has the following beneficial effects:
(1) The fragrance-expanding performance of the finally obtained plant essential oil is improved by adding specific plant components.
(2) The obtained plant essential oil has high stability, does not deteriorate after long-term storage, does not produce precipitate, and does not change color.
(3) The obtained plant essential oil can relieve stress and tension, and relieve dysphoria and anxiety.
(4) The obtained plant essential oil can improve sleep quality and improve insomnia.
(5) The temperature, time and other conditions in the alcohol extraction process are controlled, so that the obtained substances are mixed in the system and perform functions.
Detailed Description
Examples
The compositions of the examples were prepared from commercial sources, wherein Salvia sclareea L. Oil was purchased from Wo Xuan, model 8016-63-5, salvia officinalis Salvia japonica Thunb oil was purchased from Arrenia essential oil, ainsliaea argyi H.L v. & Vanit. Was purchased from Aite, ganoderma lucidum Ganoderma lucidum (Curtis) P.Karst.) was purchased from Jilin Hongyi specialty Co., ltd, ethyl acetate was purchased from Innova, density 0.902g/mL, and alpha-tocopherol was purchased from Shenzhen Philips Biotech Co.
Example 1
The example provides plant essential oil for resolving depression and aiding sleep, which comprises, by weight, 27 parts of plant components and 0.5 part of antioxidant.
The plant components are Salvia oil, oleum Artemisiae Argyi, and Ganoderma oil.
The weight ratio of the Salvia oil, the mugwort oil and the ganoderma oil in the plant components is 10:8:5:6.
the antioxidant is selected from alpha-tocopherol.
The mugwort oil and the ganoderma oil are obtained through an alcohol extraction process.
The alcohol extraction process of the wormwood oil comprises the following steps: (1) crushing; pulverizing 500g of mugwort by a pulverizer, and sieving with a 20-mesh sieve to obtain a substance A; (2) extraction: soaking the substance A in ethyl acetate with the weight of 17 times of that of the substance A for 14 days, taking out the substance A, and drying the substance A in an oven with the temperature of 70 ℃ for 12 hours to obtain a substance B; (3) extraction: adding 10 times of absolute ethyl alcohol into the substance B, and soaking for 15 days to obtain a substance C; (4) filtration, distillation: filtering the substance C, and distilling the filtrate obtained by filtering under reduced pressure at 40deg.C and vacuum degree of 10mbar for 5 hr to obtain extract, namely oleum Artemisiae Argyi.
The alcohol extraction process of the ganoderma lucidum oil comprises the following steps: (1) crushing; pulverizing 500g of Ganoderma by a pulverizer, and sieving with 20 mesh sieve to obtain substance A'; (2) extraction: soaking the substance A ' in ethyl acetate with the weight of 18 times of that of the substance A ' for 14 days, taking out the substance A ', and drying the substance A ' in an oven at 60 ℃ for 12 hours to obtain a substance B '; (3) extraction: adding absolute ethyl alcohol with the weight being 11 times that of the substance B ', and soaking for 15 days to obtain a substance C'; (4) filtration, distillation: filtering the substance C', and distilling the filtrate under reduced pressure at 40deg.C and vacuum degree of 10mbar for 5 hr to obtain extract, namely Ganoderma oil.
Example 2
The example provides a plant essential oil for resolving depression and aiding sleep, which is different from the example 1 in that the raw materials of the plant essential oil for resolving depression and aiding sleep comprise 25 parts of plant components and 0.41 part of antioxidant.
The example also provides a preparation method of the plant essential oil for resolving depression and aiding sleep, which is the same as that of the example 1.
Example 3
The present example provides a plant essential oil for resolving depression and aiding sleep, which is different from the example 1 in that the weight ratio of the salvia miltiorrhiza oil, the sage oil, the wormwood oil and the ganoderma lucidum oil in the plant components is 9:7:4:5.5.
the example also provides a preparation method of the plant essential oil for resolving depression and aiding sleep, which is the same as that of the example 1.
Example 4
The present example provides a plant essential oil for resolving depression and aiding sleep, which is different from the example 1 in that the weight ratio of the salvia miltiorrhiza oil, the sage oil, the wormwood oil and the ganoderma lucidum oil in the plant components is 8:8:2:5.
the example also provides a preparation method of the plant essential oil for resolving depression and aiding sleep, which is the same as that of the example 1.
Example 5
The example provides a plant essential oil for resolving depression and aiding sleep, which is different from the example 1 in that the raw materials of the plant essential oil for resolving depression and aiding sleep comprise 35 parts of plant components and 0.7 part of antioxidant.
The example also provides a preparation method of the plant essential oil for resolving depression and aiding sleep, which is the same as that of the example 1.
Performance test:
1. stability test: the depression-relieving and sleep-aiding plant essential oils obtained in examples 1 to 5 were placed at a low temperature of 5 ℃, a high temperature of 25 ℃ and a high temperature of 35 ℃ respectively, and after being placed for 15 days, whether precipitation occurs or not and the color change occurs were observed, and the results are shown in Table 1:
TABLE 1
| Examples | Appearance at 5 DEG C | 25℃ | 35℃ |
| 1 | No precipitate and no color change | No precipitate and no color change | No precipitate and no color change |
| 2 | No precipitate and no color change | No precipitate and no color change | No precipitate and no color change |
| 3 | No precipitate and no color change | No precipitate and no color change | No precipitate and no color change |
| 4 | Precipitation, no color change | Precipitation, no color change | Precipitation, color change |
| 5 | No precipitate and color change | No precipitate and no color change | No precipitate and no color change |
It is clear that the plant essential oil for resolving depression and aiding sleep obtained in examples 1-3 has low temperature of 5 ℃, 25 ℃ and high temperature of 35 ℃, no precipitate or color change after being placed for 15 days, long storage time and high stability.
Claims (7)
1. The plant essential oil for resolving depression and aiding sleep is characterized by comprising, by weight, 24-32 parts of plant components and 0.4-0.7 part of antioxidants;
the plant components are mugwort oil, salvia oil, ganoderma oil and Salvia oil;
the weight ratio of the Salvia oil, the mugwort oil and the ganoderma oil is (8-12): (7-10): (3-6): (5-7.5);
the antioxidant is alpha-tocopherol.
2. The plant essential oil for resolving depression and aiding sleep according to claim 1, wherein the mugwort oil and the ganoderma lucidum oil are obtained through an alcohol extraction process.
3. The plant essential oil for resolving depression and aiding sleep according to claim 2, wherein the alcohol extraction process comprises: (1) crushing; (2) extraction; (3) extracting; (4) filtration and distillation.
4. The depression-relieving and sleep-aiding plant essential oil according to claim 3, wherein an organic solvent is used in the extraction process.
5. The depression-relieving and sleep-aiding plant essential oil according to claim 4, wherein the organic solvent has a density of 0.8-1.0g/mL.
6. A method for preparing a plant essential oil for resolving depression and aiding sleep according to claim 5, wherein alcohols are added for the extraction.
7. Use of a depression-relieving, sleep-aiding plant essential oil according to claim 1, for improving mood.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111672955.8A CN115813975B (en) | 2021-12-31 | 2021-12-31 | Plant essential oil for resolving depression and aiding sleep and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111672955.8A CN115813975B (en) | 2021-12-31 | 2021-12-31 | Plant essential oil for resolving depression and aiding sleep and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115813975A CN115813975A (en) | 2023-03-21 |
| CN115813975B true CN115813975B (en) | 2023-12-12 |
Family
ID=85515563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111672955.8A Active CN115813975B (en) | 2021-12-31 | 2021-12-31 | Plant essential oil for resolving depression and aiding sleep and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115813975B (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104800430A (en) * | 2015-05-23 | 2015-07-29 | 唐赢 | Essential oil for improving depth of sleep |
| CN108703899A (en) * | 2018-08-31 | 2018-10-26 | 东莞市炫墨生物科技有限公司 | Essential oil is massaged in skin care |
-
2021
- 2021-12-31 CN CN202111672955.8A patent/CN115813975B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104800430A (en) * | 2015-05-23 | 2015-07-29 | 唐赢 | Essential oil for improving depth of sleep |
| CN108703899A (en) * | 2018-08-31 | 2018-10-26 | 东莞市炫墨生物科技有限公司 | Essential oil is massaged in skin care |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115813975A (en) | 2023-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108797214B (en) | Colored cigarette paper coating liquid with special fragrance and application thereof | |
| CN108727897B (en) | Fragrant color ink and application thereof in tipping paper | |
| CN108587786B (en) | Preparation method of anoectochilus roxburghii extract, application of anoectochilus roxburghii extract in cigarettes and cigarettes | |
| CN106074263B (en) | Herbal extract and application thereof in cosmetics | |
| CN108403495B (en) | Camellia extract and Chinese herbal medicine cosmetic containing camellia extract | |
| KR20170049353A (en) | Extraction method of high purity cordycepin | |
| CN115813975B (en) | Plant essential oil for resolving depression and aiding sleep and application thereof | |
| KR100817876B1 (en) | Isolation process for proanthocyanidin from the bark of pine tree | |
| CN109123938B (en) | Functional jewelry with effects of calming, relieving and dredging emotion congestion and use method thereof | |
| KR102349207B1 (en) | A method for extracting the active ingredient of the raw material hub at a high content and a composition containing the high content active ingredient extracted therefrom | |
| CN103222679A (en) | Method for preparing tobacco fragment extractives by high-pressure-puffing-flocculation and application of extractives | |
| CN113796565B (en) | Preparation method of vine tea flavored novel cigarette essence | |
| CN102805171B (en) | Process for utilizing tea comprehensively | |
| CN110373271B (en) | Additive for removing plant wax and method for removing plant wax | |
| CN104886764A (en) | Production method of eucalyptus leaf extract for cigarettes | |
| CN114106008A (en) | Diterpene quinone compound extracted and separated from salvia miltiorrhiza bunge and method and application thereof | |
| CN113180277A (en) | Application of saffron natural pigment in novel tobacco and preparation method thereof | |
| CN101422518B (en) | Preparation method of loquat flower extract | |
| CN101912148B (en) | Extraction method for blackberry lily extractum and application of blackberry lily extractum in cigarettes | |
| CN116270768B (en) | Extraction and separation method of polyphenol substances of sporophore of phellinus linteus | |
| KR102538693B1 (en) | Manufacturing method of cosmetic composition using lactobacillus plantarum fermented water | |
| Gao et al. | ACE inhibitory, antitumor and antioxidant activities of submerged culture materials of three medicinal mushrooms | |
| CN115414421B (en) | Extraction method and application of active ingredients of cortex dictamni | |
| CN113292622B (en) | Method for extracting beta-sitosterol from pimpinella brachycarpa and application of beta-sitosterol | |
| CN107557162A (en) | A kind of cinnamomum camphora Cypress ethereal oil |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |